期刊文献+

匹多莫德联合伐昔洛韦治疗带状疱疹疗效观察 被引量:8

Observation on the Curative Effect of Pidotimod Combined with Valaciclovir on Herpes Zoster
下载PDF
导出
摘要 目的观察匹多莫德联合伐昔洛韦治疗带状疱疹的疗效。方法 116例带状疱疹患者随机分为两组,观察组72例每日予盐酸伐昔洛韦胶囊0.3 bid同时予匹多莫德片0.8g bid共7天;对照组44例每日予盐酸伐昔洛韦胶囊0.3 bid共7天。结果观察组总有效率明显优于对照组(P<0.01),观察组的平均止疱时间、止痛时间、结痂时间均明显短于对照组(P<0.05),且无后遗神经痛发生。结论匹多莫德联合伐昔洛韦治疗带状疱疹比单用伐昔洛韦治疗带状疱疹起效更快、疗程更短、疗效更好。 Objective To observe the curative effect of pidotimod combined with valaciclovir on herpes zoster.Methods 116 cases with herpes zoster were randomly divided into 2 groups: observation group(n=72) and control group(n=44);valaciclovir hudrochloride capsules of 0.3g once,twice a day,were given to patients in both groups while pidotimod tablets of 0.8g once,twice a day were added to patients in observation group;the course of both groups lasted for 7 days.Results The total effective rate in observation group was much superior to that in control group(P〈0.01);the average time of blister elimination,analgesia and incrustation in observation group was much shorter than that in control group(P〈0.05),and no post herpetic neuralgia occurred in observation group.Conclusions Pidotimod combined with valaciclovir is of quicker effect-taking,shorter course and better effect in treating herpes zoster.
作者 王艺颖
出处 《西南军医》 2010年第4期638-640,共3页 Journal of Military Surgeon in Southwest China
关键词 带状疱疹 匹多莫德 伐昔洛韦 pidotimod valaciclovir treatment herpes zoster curative effect
  • 相关文献

参考文献5

二级参考文献14

  • 1徐学瑛 李元 等.一个改进的体液免疫测定方法-溶血素测定法[J].药学学报,1979,14(7):443-443.
  • 2张炜,国外医学皮肤性病学分册,1996年,22卷,257页
  • 3劳力民,中华皮肤科杂志,1996年,29卷,437页
  • 4谢志纯,湖南医科大学学报,1995年,20卷,171页
  • 5高庆林,中华皮肤科杂志,1989年,22卷,294页
  • 6Coppi G, Falcone A, Manzardo S.Protective effects of pidotimod against experimental bacterial infections in mice[J]. Arzneimittelforsch, 1994; 44: 1417-21
  • 7Dianzani C, Colangelo D, Tonso E, Guidotto S, Viano I. In vivo antiviral effects of pidotimod[J]. Arzneimittelforsch,1994; 44: 1431-3
  • 8Han CW, Imamura M, Hashino S, Zhu X, Tanaka J, Imai K, et al. Differential effects of the immunosuppressants cyclosporine A, FK506 and KW2210 on cytoking gene expression[J]. Bone Marrow Transplant,1995;15:733-9
  • 9Tan HR, Dong Q, Cao LZ, Baishanbo A, Li JM. The effect of immune-potentiating action and expressing lymphocyte factor of pidotimod[J]. J Beijing Med Univ,1999;31:38-41
  • 10Migliorati G, Nicoletti I, Riccardi C. Immunomodulating activity of pidotimod[J]. Arzneimittelforsch,1994; 44: 1421-4

共引文献201

同被引文献113

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部